These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Investigation into early stage fatigue-damage accumulation in glutaraldehyde-fixed bovine pericardium using a novel equibiaxial bulge inflation system. Whelan A; O'Brien G; Szagdaj A; O'Reilly D; Lally C J Mech Behav Biomed Mater; 2021 Sep; 121():104588. PubMed ID: 34091153 [TBL] [Abstract][Full Text] [Related]
47. Detection of remnant proteolytic activities in unimplanted glutaraldehyde-treated bovine pericardium and explanted cardiac bioprostheses. Simionescu D; Simionescu A; Deac R J Biomed Mater Res; 1993 Jun; 27(6):821-9. PubMed ID: 8408112 [TBL] [Abstract][Full Text] [Related]
48. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse. Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076 [TBL] [Abstract][Full Text] [Related]
49. Use of glutaraldehyde and formaldehyde to process tissue heart valves. Woodroof EA J Bioeng; 1978 Apr; 2(1-2):1-9. PubMed ID: 98522 [No Abstract] [Full Text] [Related]
50. Binding of preformed xenoantibodies to porcine bioprosthetic valves. Sanchez JA; Marboe CC; Auteri JS; Jeevanandum V; Edwards NM; Berger CL; Rose EA Ann Thorac Surg; 1991 Jan; 51(1):30-3. PubMed ID: 1898692 [TBL] [Abstract][Full Text] [Related]
51. Durability of glutaraldehyde-fixed pericardial valve prostheses: clinical and animal experimental studies. Valente M; Minarini M; Ius P; Talenti E; Bortolotti U; Milano A; Thiene G J Heart Valve Dis; 1992 Nov; 1(2):216-24. PubMed ID: 1341632 [TBL] [Abstract][Full Text] [Related]
52. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model. Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841 [TBL] [Abstract][Full Text] [Related]
53. Shelf-life of bioprosthetic heart valves: a structural and mechanical study. Julien M; Létouneau DR; Marois Y; Cardou A; King MW; Guidoin R; Chachra D; Lee JM Biomaterials; 1997 Apr; 18(8):605-12. PubMed ID: 9134160 [TBL] [Abstract][Full Text] [Related]
54. Two stage EDTA anti-calcification method for bioprosthetic heart valve materials. Sucu N; Karaca K; Yilmaz N; Cömelekoglu U; Aytacoglu BN; Tamer L; Ozeren M; Dondas HA; Oğuz Y; Ogenler O; Dikmengil M Med Sci Monit; 2006 Jun; 12(6):MT33-8. PubMed ID: 16733494 [TBL] [Abstract][Full Text] [Related]
55. Prevention of calcification with TPEN in pericardial bioprosthetic heart valve material. Döndaş HA; Yilmaz N; Cömelekoğlu U; Tamer L; Sucu N; Aytaçoğlu BN; Ozeren M; Köse N; Dikmengil M Anadolu Kardiyol Derg; 2007 Dec; 7(4):365-70. PubMed ID: 18065330 [TBL] [Abstract][Full Text] [Related]
56. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole. Pathak YV; Boyd J; Levy RJ; Schoen FJ Biomaterials; 1990 Nov; 11(9):718-23. PubMed ID: 2128616 [TBL] [Abstract][Full Text] [Related]
57. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering. Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635 [TBL] [Abstract][Full Text] [Related]